Incidence, mitigation, and management of neurologic adverse events in the CARTITUDE-2 study of patients with multiple myeloma treated with ciltacabtagene autoleucel (cilta-cel) Meeting Abstract
| Authors: | Jakubowiak, A.; Parekh, S.; Madduri, D.; Santomasso, B.; Perez-Larraya, J. G.; van de Donk, N. W. C. J.; Arnulf, B.; Mateos, M. V.; De Braganca, K. C.; Varsos, H.; Carrasco-Alfonso, M. J.; Akram, M.; Lendvai, N.; Jackson, C. C.; Olyslager, Y.; Zudaire, E.; Li, C.; Geng, D.; Einsele, H.; Cohen, A. |
| Abstract Title: | Incidence, mitigation, and management of neurologic adverse events in the CARTITUDE-2 study of patients with multiple myeloma treated with ciltacabtagene autoleucel (cilta-cel) |
| Meeting Title: | 9th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | neurotoxicity; multiple myeloma; mm; car-t; ciltacabtagene autoleucel |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 21 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Sep 8-11 |
| Meeting Location: | Virtual event |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-09-01 |
| Start Page: | S421 |
| End Page: | S422 |
| Language: | English |
| ACCESSION: | WOS:000691910500383 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(21)01945-5 |
| Notes: | Meeting Abstract: MM-112 -- Source: Wos |
